Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FZS90
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $197,797
Award facts
- Contract value 100% obligated
- $197,797.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $197,797.20 to DMS Pharmaceutical Group Inc. on September 25, 2025, for the supply of Entyvio 300 mg vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 17, 2025, and will be performed at the vendor's facility in Park Ridge, Illinois. This award utilizes no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its status as a woman-owned small business.
DMS Pharmaceutical Group Inc. is an established pharmaceutical wholesaler that has served as a critical supplier to the Defense Logistics Agency since 2001. This delivery order is issued under the company's substantial Indefinite Delivery Contract with the DLA valued at $499,999,999 and extending through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products including branded and generic prescription medications, biologics, and medical consumables to support Department of Defense healthcare facilities nationwide. Entyvio, a biologic treatment for inflammatory bowel diseases, represents one of the specialized pharmaceutical products within this broader supply relationship.
Quick answers
Who was awarded contract SPE2DB25FZS90?
SPE2DB25FZS90 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FZS90 worth?
The government has obligated $197,797 on SPE2DB25FZS90.
Is contract SPE2DB25FZS90 an order under another contract?
Yes. SPE2DB25FZS90 is a delivery order under SPE2DB22D9244, an indefinite delivery contract.
Was contract SPE2DB25FZS90 competed?
The extent of competition for SPE2DB25FZS90 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award